Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

[Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].

Zhang B, Zhong DW, Wang QW, Miao XY, Dai WD, Liu C, Pan KH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Apr;26(4):368-70, 373. Chinese.

PMID:
20368117
[PubMed - indexed for MEDLINE]
2.

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS.

Gastroenterology. 2006 Apr;130(4):1117-28.

PMID:
16618406
[PubMed - indexed for MEDLINE]
3.

[The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].

Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.

Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1553-6. Chinese.

PMID:
12609066
[PubMed - indexed for MEDLINE]
4.

JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.

You Z, Xu D, Ji J, Guo W, Zhu W, He J.

Clin Transl Oncol. 2012 Feb;14(2):143-9. doi: 10.1007/s12094-012-0774-6.

PMID:
22301404
[PubMed - indexed for MEDLINE]
5.

EGFR is phosphorylated at Ty845 in hepatocellular carcinoma.

Kannangai R, Sahin F, Torbenson MS.

Mod Pathol. 2006 Nov;19(11):1456-61. Epub 2006 Aug 25.

PMID:
16936701
[PubMed - indexed for MEDLINE]
Free Article
6.

Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas.

Tu Y, Zhong Y, Fu J, Cao Y, Fu G, Tian X, Wang B.

Med Oncol. 2011 Mar;28(1):15-23. doi: 10.1007/s12032-010-9435-1. Epub 2010 Feb 5.

PMID:
20135364
[PubMed - indexed for MEDLINE]
7.

ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.

Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, Peng SY, Lai PL, Hsu HC.

Clin Cancer Res. 2008 Aug 1;14(15):4814-20. doi: 10.1158/1078-0432.CCR-07-5262.

PMID:
18676753
[PubMed - indexed for MEDLINE]
Free Article
8.

[Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].

Zhang G, Zhang SJ, Zhao YF, Wu Y, Li Z, Wang JX.

Zhonghua Wai Ke Za Zhi. 2007 Apr 1;45(7):499-502. Chinese.

PMID:
17686315
[PubMed - indexed for MEDLINE]
9.

Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.

Liu YB, Gao SL, Chen XP, Peng SY, Fang HQ, Wu YL, Peng CH, Tang Z, Xu B, Wang JW, Deng GL, Li HJ, Feng XD, Qian HR.

World J Gastroenterol. 2005 Mar 7;11(9):1378-81.

PMID:
15761980
[PubMed - indexed for MEDLINE]
Free Article
10.

Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.

Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M, Aozasa K.

J Clin Oncol. 2003 Feb 1;21(3):447-52.

PMID:
12560433
[PubMed - indexed for MEDLINE]
Free Article
11.

Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway.

Di Bona D, Cippitelli M, Fionda C, Cammà C, Licata A, Santoni A, Craxì A.

J Hepatol. 2006 Aug;45(2):271-9. Epub 2006 Mar 9.

PMID:
16595158
[PubMed - indexed for MEDLINE]
12.

Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.

Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F.

Clin Cancer Res. 2006 Oct 1;12(19):5673-9.

PMID:
17020969
[PubMed - indexed for MEDLINE]
Free Article
13.

[Ovarian carcinoma cell inhibits T cell JAK-STAT signal transduction pathway, an experimental study].

Wang H, Xie X, Lü WG, Ye DF, Chen HZ, Li X, Cheng Q.

Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):972-5. Chinese.

PMID:
12899799
[PubMed - indexed for MEDLINE]
15.

[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].

Chen G, Luo DZ, Wang Y, Liao ZL, Zhang MY.

Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):113-7. Chinese.

PMID:
17493386
[PubMed - indexed for MEDLINE]
16.

Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.

Zeng ZJ, Yang LY, Ding X, Wang W.

World J Gastroenterol. 2004 Dec 1;10(23):3414-8.

PMID:
15526358
[PubMed - indexed for MEDLINE]
Free Article
17.

Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.

Yang W, Lv S, Liu X, Liu H, Yang W, Hu F.

Jpn J Clin Oncol. 2010 Nov;40(11):1053-9. doi: 10.1093/jjco/hyq086. Epub 2010 Jun 3.

PMID:
20522449
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

[Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].

Zhou Q, Liang LJ, Peng BG, Zhen YY.

Ai Zheng. 2006 Nov;25(11):1433-8. Chinese.

PMID:
17094916
[PubMed - indexed for MEDLINE]
20.

Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis.

Sasaki Y, Yamamura H, Kawakami Y, Yamada T, Hiratsuka M, Kameyama M, Ohigashi H, Ishikawa O, Imaoka S, Ishiguro S, Takahashi K.

Cancer. 2002 Mar 15;94(6):1777-86.

PMID:
11920541
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk